✦ LIBER ✦

Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention and Abciximab or Tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)

✍ Scribed by Nevio Taglieri; Francesco Saia; Vincenzo Guiducci; Stefano Tondi; Federico Conrotto; Cinzia Marrozzini; Guido Rocchi; Elena Biagini; Maria Letizia Bacchi Reggiani; Paola Giacometti; Giancarlo Piovaccari; Antonio Manari; Antonio Marzocchi

Book ID: 113445382
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 443 KB
Volume: 103
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2008.11.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracoronary versus intravenous bolus a

Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function

✍ Ingo Eitel; Josef Friedenberger; Georg Fuernau; Annett Dumjahn; Steffen Desch; G 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 265 KB

Sex-specific benefits of sirolimus-eluti

Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial

✍ Giuseppe Ferrante; Patrizia Presbitero; Elena Corrada; Gianluca Campo; Leonardo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Comparison of very early treatment with

Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: The Swedish Early Decision (SWEDES) reperfusion trial

✍ Leif Svensson; Mikael Aasa; Mikael Dellborg; C. Michael Gibson; Ajay Kirtane; Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Outcomes of Patients Treated With Triple

Outcomes of Patients Treated With Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial)

✍ Eugenia Nikolsky; Roxana Mehran; George D. Dangas; Jennifer Yu; Helen Parise; Ke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Prevalence and Prognostic Implications o

Prevalence and Prognostic Implications of ST-Segment Deviations from Ambulatory Holter Monitoring After ST-Segment Elevation Myocardial Infarction Treated With Either Fibrinolysis or Primary Percutaneous Coronary Intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy)

✍ Lars Idorn; Dan Eik Høfsten; Kristian Wachtell; Henning Mølgaard; Kenneth Egstru 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 278 KB

TCT-493 The Clinical Utility of High-Sen

TCT-493 The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

✍ H. Boden; T.A.N. Ahmed; M.A. Velders; B.L. van der Hoeven; G.E. Hoogslag; M. Boo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB